HSF1 and constitutively active HSF1 improve vascular endothelial function (heat shock proteins improve vascular...

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Cellular Signaling

Background:

• Statins exhibit pleiotropic effects beyond cholesterol reduction.
• Heat shock factor 1 (HSF1) is implicated in cellular stress responses.
• Vascular endothelial cells play a critical role in cardiovascular homeostasis.

Purpose of the Study:

• To investigate the role of HSF1 in statin-mediated vascular effects.
• To elucidate the mechanisms by which HSF1 influences endothelial cell function.
• To explore the therapeutic potential of HSF1 modulation in cardiovascular disease.

Main Methods:

• Examining HSF1 nuclear translocation in response to statins.
• Utilizing decoy oligonucleotides to inhibit HSF1-mediated gene expression.
• Measuring expression levels of heat shock proteins (HSP70, HSP90), endothelial nitric oxide synthase (eNOS), thrombomodulin, endothelin-1 (ET-1), and plasminogen activator inhibitor-1 (PAI-1).
• Employing a constitutively active form of HSF1 for comparative analysis.

Main Results:

• Statin-induced HSF1 nuclear translocation was confirmed.
• Inhibition of HSF1 signaling reduced statin-induced expression of HSP70, eNOS, and thrombomodulin.
• Increased HSF1 expression in vascular endothelial cells correlated with elevated eNOS and thrombomodulin, and reduced ET-1 and PAI-1.
• Heat shock proteins, particularly HSP70 and HSP90, induced eNOS and thrombomodulin while reducing PAI-1.
• Constitutively active HSF1 demonstrated enhanced efficacy in modulating these factors compared to wild-type HSF1.

Conclusions:

• HSF1 activation by statins promotes the expression of anticoagulation and relaxation factors in vascular endothelial cells.
• Heat shock proteins induced by HSF1 contribute to beneficial vascular effects.
• Modulation of HSF1 activity presents a potential therapeutic strategy for cardiovascular disease treatment.